One of my research contracting account managers turned me towards you and your platform on LinkedIn. I havent been disappointed in the slightest. You are doing amazing work and definitely have so many in-depth videos and invaluable insights. Thank you Dan!
Chris had a point behind the kidding statement, log makes sense,but P.I should act sensibly and be knowledgeable, of course for the benefit of the patients without co intervention/ deviation from protocol😇
@dansfera what do you when sponsors do not accept staff wet signatures? Considering people have different signatures,depending on the day? Without lack of automated docusign system?
awesome as always, am so lucky to have found this webinar. First and foremost can you be kind enough to share these slides? Secondly, in relation to the financial disclosure slide, if there is no IP hence no pharmaceutical company, do we forego this disclosure since it says ..."no financial interest in the pharmaceutical company conducting the study" ? or is the sentence then just modified to the type of study? i hope I am making sense, I am from Zambia English is not native and am new to research at this level, just left clinical practice. Thanks
concerning IRB approval, even if the site has no ongoing study in that particular year should they still have a yearly renewed approval or this is done just with receipt of a study?
Thanks for this webinar, it is very informative. please where can I get GCP training certification...which institution/site offers the certification training?? Thank you..
Do all subjects start on same date.....for example for a Phase 2 trial of may be 10 to 20 Subjects .....are they all starting same day upon Site Initiation
The best cllinical research webinar on regulatory requirements for SSU that I've seen. Thank you!
One of my research contracting account managers turned me towards you and your platform on LinkedIn. I havent been disappointed in the slightest. You are doing amazing work and definitely have so many in-depth videos and invaluable insights. Thank you Dan!
Welcome aboard! Thank you
Great webinar! A lot of useful knowledge with the eye of practitioner.
Nice job guys
thank you!
Chris had a point behind the kidding statement, log makes sense,but P.I should act sensibly and be knowledgeable, of course for the benefit of the patients without co intervention/ deviation from protocol😇
some serious stuff..goodnight
Awesome! Thanks
How do get all PI and Sub I to sign all required documents in a timely matter? Docusign? Wetsign? How are you able to get staff to sign? fast
Lots of bothering them in person
@dansfera what do you when sponsors do not accept staff wet signatures? Considering people have different signatures,depending on the day? Without lack of automated docusign system?
thank you dan for the excllent video , is study start up just in phase 1 or all single phase we do same steps and documents ?
Any study
awesome as always, am so lucky to have found this webinar. First and foremost can you be kind enough to share these slides? Secondly, in relation to the financial disclosure slide, if there is no IP hence no pharmaceutical company, do we forego this disclosure since it says ..."no financial interest in the pharmaceutical company conducting the study" ? or is the sentence then just modified to the type of study? i hope I am making sense, I am from Zambia English is not native and am new to research at this level, just left clinical practice. Thanks
concerning IRB approval, even if the site has no ongoing study in that particular year should they still have a yearly renewed approval or this is done just with receipt of a study?
Thanks for this webinar, it is very informative. please where can I get GCP training certification...which institution/site offers the certification training?? Thank you..
Basic things in the forms on all countries are the same.
concerning credentials, as we file renewed licenses, how far back can we continue to keep expired licenses on file or can we discard?
Please help me to understand initial crucial documents require to start study
Difference between SUSARA and CIOMA?
Dont know what cioma is
Is this applicable for the uk
Yes
I have a bs in science 2012 , i also have phlebotomist certification, i want get in field, what more certification or skills i need to get in field
just start at a research clinic near you
Do all subjects start on same date.....for example for a Phase 2 trial of may be 10 to 20 Subjects .....are they all starting same day upon Site Initiation
No. Subjects can start whenever they can. Sites cannot screen any until after siv. Know the difference between enrollment window and study duration
@@dansfera just saw this clip.....www.theclinicaltrialsguru.com/blog1/enrollment-window-vs-study-length-in-clinical-trials
@@dansfera can I have your mobile number or email address